Pharmacokinetic, Pharmacodynamic, and Tolerability Profiles of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin: A 4-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIa Study in Japanese Type 2 Diabetes Patients
Yoshiharu Horie, Shigeto Kanada, Hirotaka Watada, Akiko Sarashina, Atsushi Taniguchi, Naoyuki Hayashi, Eva U. Graefe-Mody, Hans-Juergen Woerle, Klaus A. DugiVolume:
33
Year:
2011
Language:
english
Pages:
17
DOI:
10.1016/j.clinthera.2011.06.005
File:
PDF, 1.18 MB
english, 2011